OMV's 29% Rally Collides with a 47% Earnings Miss – and a Skeptical Barclays

OMV's stock surges 28% YTD on high dividend yield, but Barclays warns of 15% downside amid weak Q1 earnings, hedging losses, and delayed Borouge IPO.

The Austrian energy group OMV has been on a tear this year, its stock surging to within striking distance of a 52-week high. At €62.55 on Friday, the shares have gained 28.77% since January, a blistering run that has left the company trading well above the price target set by Barclays. The investment bank, which rates the stock "Underweight" with a €53 target, sees a widening gap between market optimism and the underlying fundamentals.

The disconnect is stark. OMV's proposed total dividend of €4.40 per share – equivalent to a roughly 7% yield at current levels – has captured investor enthusiasm. Under a revised payout model, half of the dividends from the Borouge chemicals joint venture will now flow directly to shareholders. Yet that very engine of distribution is sputtering: the planned initial public offering of Borouge Group in Abu Dhabi has been pushed back to 2027, halving the dividend income from the venture this year to around $250 million.

The first-quarter numbers laid bare the operational strain. Earnings per share came in at just €0.99, less than half the €1.89 analysts had penciled in. The closure of the Strait of Hormuz at the end of February triggered hedging losses in the hundreds of millions, while the refining margin collapsed from over €10 per barrel to €6.65. The company now expects a full-year average Brent crude price of around $65 and production to dip slightly below 300,000 barrels of oil equivalent per day.

Barclays analyst Lydia Rainforth has trimmed her earnings forecasts in response. She now sees EPS of €7.35 for 2026, slipping to €7.22 in 2027 and €6.94 in 2028. That is not a cliff-edge, but it signals a steady erosion of profitability as market conditions normalise, margins compress and chemicals demand softens. Crucially, the dividend outlook remains generous: Barclays models payouts of €4.50 for 2026, rising to €4.93 and €4.91 in the following two years.

Such a trajectory puts the spotlight squarely on cash flow. Sustaining those distributions while earnings decline requires robust free cash flow generation – something that can quickly unravel if oil prices, refinery margins or chemical demand take a turn for the worse. The tension between a dividend-led equity story and a weakening operational backdrop is precisely what underpins Barclays' cautious stance.

A leadership change adds another layer. On 1 September, Emma Delaney, a veteran of bp, will take over as CEO – the first woman to lead OMV. Finance chief Reinhard Florey steps up to deputy chairman. The new team inherits a stock that has priced in plenty of good news, leaving little room for further disappointments.

On a seven-day view, the shares are up 3.75%; over the past month, they have gained 7.32%. Technically, the chart looks strong. But with Barclays pointing to a 15% downside from current levels, the market is effectively wagering that the operational headwinds – from Hormuz disruption to Borouge delays – are temporary, and that the dividend promise is secure. That bet has paid off handsomely so far, but the margin for error is shrinking.